Navigation Links
EDAP TMS S.A. Announces $20 Million Placement to Fund US Clinical Studies
Date:10/30/2007

of the warrants and payable in interest.

The securities issued in connection with the private placement referenced herein have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be, absent any exemption therefrom, any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About EDAP TMS S.A.

EDAP TMS S.A. develops and markets Ablatherm, the most advanced and clinically proven choice for High Intensity Focused Ultrasound (HIFU) treatment of localized prostate cancer. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. Ablatherm-HIFU is generally recommended for patients with localized prostate cancer (stages T1-T2) who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment. The company is also developing this technology for the potential treatment of certain other types of tumors. EDAP TMS S.A. also produces and

commercializes medical equipment for treatment of urinary tract stones using Extra-corporeal Shockwave Lithotripsy (ESWL).

To sign up for alerts please visit: http://www.b2i.us/irpass.asp?BzID=1053&to=ea&s=0

In addition to historical information, this press release contains forward-looking statements that involve risks and uncertainties. These include statements regarding the Company's growth and expansion plans. Such statements are based on management's current expectations and are subject to a number
'/>"/>

SOURCE EDAP TMS S.A.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression innovator, SIGVARIS ... men. , For style that’s quick on its feet, men will love this ... news for men everywhere because a simple change in socks can dramatically help improve ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... pipeline review 2015” provides comprehensive information on the pipeline products with comparative ... negative pressure wound therapy (NPWT) with 22 market data tables and 4 ...
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough ... wrist pain treatment. Dr. Lev Kalika, founder of New York Dynamic Neuromuscular ... authority on the conservative treatment of back, hip, knee and shoulder pain as ...
(Date:7/2/2015)... ... , ... Hand sanitizers have become extremely popular with an annual industry growth ... advocate and radio host Sharon Kleyne, hand sanitizers can effectively decrease the presence of ... sanitizers must be applied correctly and users must be aware of its limitations. ...
(Date:7/2/2015)... Dallas, TX (PRWEB) , ... July 02, 2015 ... ... and the overall status of the Gelatin Capsule manufacturers. The report is a ... industry. , The report depicts the global and Chinese market for the Gelatin ...
Breaking Medicine News(10 mins):Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4
... be reacting to varying degrees of energy loss during aerobic ... predisposition. How our bodies react to exercise programs is genetic ... like the level of blood glucose in the body etc. ... scientists from Washington University School of Medicine, exercise can help ...
... the first time in India ,German Remedies, a part of ... treatment // of chronic lymphocytic leukemia. Chronic Lymphocytic Leukemia (CLL) ... progressive disease, which at present has no cure. The disease ... becomes progressively more common with increasing age. ,Fludarabine ...
... scan study of the smokers reveals that the smokers may ... brain’s sensitivity to smoking. ,Researchers have found that the ... in smokers according to the brain responses to the smoking ... into the brain images of smokers in a bid to ...
... Pharma-Planta, wants to produce vaccines and other treatments for major ... to start clinical trials by the year 2009. The project's ... greatest benefit to developing nations where they feel that access ... keeping in mind that human health and the environment are ...
... pounds above ideal body weight. Obesity is slowly becoming a global ... a recent report the number of obese adults in the U.S. ... 15 percent in 1970. ,Obesity not only causes problems ... etc. This has resulted in spiraling of private healthcare costs and ...
... that uncomplicated twin pregnancies may be more risky to ... Imperial College London report that normal monochorionic diamniotic twin ... monochorionic diamniotic twin pregnancy, the twin fetuses share the ... are the most common form of twin pregnancies that ...
Cached Medicine News:Health News:Producing Vaccines from genetically modified crops 2
(Date:7/2/2015)... LONDON , July 2, 2015 ... commitment to improving access to HIV treatments   ... a strategic manufacturing agreement to enable production in ... additional source of the dolutegravir active pharmaceutical ingredient (API), and ... the finished product (dolutegravir 50mg, marketed under the name Tivicay®) ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
(Date:7/1/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Business Challenges, Emerging Technologies, Competitive Landscape" ... New Frontiers in European Clinical Chemistry and ... Landscape is a new five-country strategic analysis ...
Breaking Medicine Technology:ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 22015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 2
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... in Elderly AML) Phase 2 clinical,trial of voreloxin ... The REVEAL-1 trial is being conducted in previously ... are unlikely to,benefit from standard induction therapy. The ...
... EASTON, Mass., May 21 Pressure,BioSciences, Inc. (Nasdaq: ... the New York University (NYU) School of Medicine, ... Public Health made presentations,highlighting the advantages of the ... scientific meetings earlier this week.,There were three oral ...
Cached Medicine Technology:Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4
... The ODEI750D cameras are a new generation of ... between digital and video imaging. Images are captured ... in both video and digital formats. Video signals ... images are sent to the PC as uncompressed ...
Bench Top Horizontal (clean bench) Airflow Cabinet...
... biocompatibility testing at various temperatures, this ... through a clean heating unit to ... to 140F. Transparent panels allow full ... easy access to the work area. ...
... hood ventilates and purifies hazardous chemical ... exhaust. Bonded charcoal filters remove most ... clearance (with access shield open) accommodates ... options include final HEPA filter, work ...
Medicine Products: